Coyote Bioscience

Founded in 2009, Coyote Bioscience Co., Ltd. is a national high-tech enterprise specializing in molecular diagnostic point-of-care testing (POCT). The company focuses on collaborative product development across various fields, including instruments, reagents, system platforms, artificial intelligence, and big data. Headquartered in Beijing, Coyote has established R&D centers in Zhongguancun, Beijing, and Silicon Valley, USA, along with production facilities in Beijing, Tianjin, and Jiangsu, and third-party testing laboratories in Beijing and Tianjin. Driven by technological innovation, Coyote has successfully developed three generations of advanced molecular diagnostic products. The company has built a robust R&D and mass production platform for molecular POCT technologies, boasting independent intellectual property rights and domestically manufactured core components that meet internationally advanced standards. Utilizing a fully automated molecular POCT diagnostic robot platform, ...